Multiple sclerosis: Autoimmunity and viruses

Current Opinion in Rheumatology

Volumn 25, Issue 4, 2013, Pages 496-501

  Cusick, Matthew F ^a   Libbey, Jane E ^a   Fujinami, Robert S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

autoreactive; CD8+ cytotoxic T lymphocytes; dual T cell receptor

Indexed keywords

MESSENGER RNA; T LYMPHOCYTE RECEPTOR;

BURKITT LYMPHOMA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; DISEASE COURSE; ENDOGENOUS RETROVIRUS; HERPES VIRUS; HOST; IMMUNE RESPONSE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEASLES VIRUS; MULTIPLE SCLEROSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; THYMUS; TORQUE TENO VIRUS; VIRUS REPLICATION;

AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; LYMPHOCYTE ACTIVATION; MULTIPLE SCLEROSIS; RECEPTORS, ANTIGEN, T-CELL; VIRUS DISEASES; VIRUS REPLICATION;

EID: 84879888068     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e328362004d     Document Type: Review

References (66)

1. Libbey JE, Fujinami RS. Potential triggers of MS. Results Probl Cell Differ 2010; 51:21-42.
2. Virtanen JO, Jacobson S. Viruses and multiple sclerosis. CNS Neurol Disord Drug Targets 2012; 11:528-544.
3. Owens GP, Gilden D, Burgoon MP, et al. Viruses and multiple sclerosis. Neuroscientist 2011; 17:659-676.
4. Kakalacheva K, Munz C, Lunemann JD. Viral triggers of multiple sclerosis. Biochim Biophys Acta 2011; 1812:132-140.
5. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000; 343:938-952.
6. Wootla B, Eriguchi M, Rodriguez M. Is multiple sclerosis an autoimmune disease? Autoimmune Dis 2012; 2012:969657.
7. Brown A, McFarlin DE, Raine CS. Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. Lab Invest 1982; 46:171-185. (Pubitemid 12181058)
8. Lassmann H. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models. Exp Neurol 2010; 225:2-8.
9. Hafler DA. Multiple sclerosis. J Clin Invest 2004; 113:788-794. (Pubitemid 38544133)
10. Kidd D, Barkhof F, McConnell R, et al. Cortical lesions in multiple sclerosis. Brain 1999; 122:17-26. (Pubitemid 29046269)
11. De Stefano N, Matthews PM, Filippi M, et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003; 60:1157-1162. (Pubitemid 36418778)
12. Geurts JJ, Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol 2008; 7:841-851.
13. Magliozzi R, Serafini B, Rosicarelli B, et al. B-cell enrichment and epstein-barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis. J Neuropathol Exp Neurol 2013; 72:29-41.
14. Bjartmar C, Kidd G, Mork S, et al. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 2000; 48:893-901.
15. Dutta R, McDonough J, Chang A, et al. Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients. Brain 2007; 130:2566-2576. (Pubitemid 47511716)
16. Libbey JE, Fujinami RS. Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines. Vaccine 2012; 29:3356-3362.
17. Steinman L, Zamvil SS. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol 2006; 60:12-21.
18. Kriesel JD, White A, Hayden FG, et al. Multiple sclerosis attacks are associated with picornavirus infections. Mult Scler 2004; 10:145-148. (Pubitemid 38499905)
19. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991; 38:1-15.
20. Hafler DA, Compston A, Sawcer S, et al. Risk alleles for multiple sclerosis identified by a genomewide study. The International Multiple Sclerosis Genetics Consortium. N Engl J Med 2007; 357:851-862. (Pubitemid 47347319)
21. Matullo CM, O'Regan KJ, Curtis M, Rall GF. CNS recruitment of CD8p T lymphocytes specific for a peripheral virus infection triggers neuropathogenesis during polymicrobial challenge. PLoS Pathog 2011; 7:e1002462.
22. Borkosky SS, Whitley C, Kopp-Schneider A, et al. Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis. PLoS One 2012; 7:e32160.
23. Perron H, Garson JA, Bedin F, et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci USA 1997; 94:7583-7588. (Pubitemid 27345359)
24. Brudek T, Christensen T, Aagaard L, et al. B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity. Retrovirology 2009; 6:104.
25. Perron H, Germi R, Bernard C, et al. Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler 2012; 18:1721-1736.
26. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409:860-921. (Pubitemid 32165345)
27. Blond JL, Lavillette D, Cheynet V, et al. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol 2000; 74:3321-3329. (Pubitemid 30143757)
28. Patience C, Takeuchi Y, Cosset FL, Weiss RA. Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells. J Virol 1998; 72:2671-2676. (Pubitemid 28175501)
29. Johnston JB, Silva C, Holden J, et al. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann Neurol 2001; 50:434-442. (Pubitemid 32938886)
30. Antony JM, Deslauriers AM, Bhat RK, et al. Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants? Biochim Biophys Acta 2011; 1812:162-176.
31. Laska MJ, Brudek T, Nissen KK, et al. Expression of HERV-Fc1, a human endogenous retrovirus, is increased in patients with active multiple sclerosis. J Virol 2012; 86:3713-3722.
32. Mameli G, Poddighe L, Mei A, et al. Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis. PLoS One 2012; 7:e44991.
33. Nexo BA, Christensen T, Frederiksen J, et al. The etiology of multiple sclerosis: genetic evidence for the involvement of the human endogenous retrovirus HERV-Fc1. PLoS One 2011; 6:e16652.
34. Petersen T, Moller-Larsen A, Ellermann-Eriksen S, et al. Effects of interferonbeta therapy on elements in the antiviral immune response towards the human herpesviruses EBV, HSV, and VZV, and to the human endogenous retroviruses HERV-H and HERV-W in multiple sclerosis. J Neuroimmunol 2012; 249:105-108.
35. Booss J, Esiri MM, Tourtellotte WW, Mason DY. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci 1983; 62:219-232. (Pubitemid 14176251)
36. Gay FW, Drye TJ, Dick GW, Esiri MM. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. Brain 1997; 120:1461-1483.
37. BabbéH, Roers A, Waisman A, et al. Clonal expansions of CD8p T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000; 192:393-404. (Pubitemid 30629164)
38. Bitsch A, Schuchardt J, Bunkowski S, et al. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000; 123:1174-1183. (Pubitemid 30312109)
39. McMahon RM, Friis L, Siebold C, et al. Structure of HLA-A-0301 in complex with a peptide of proteolipid protein: insights into the role of HLA-A alleles in susceptibility to multiple sclerosis. Acta Crystallogr D Biol Crystallogr 2011; 67:447-454.
40. Friese MA, Jakobsen KB, Friis L, et al. Opposing effects of HLA class I molecules in tuning autoreactive CD8p T cells in multiple sclerosis. Nat Med 2008; 14:1227-1235.
41. Fogdell-Hahn A, Ligers A, Gronning M, et al. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 2000; 55:140-148. (Pubitemid 30103439)
42. Bertrams HJ, Kuwert EK. Association of histocompatibility haplotype HLA-A3- B7 with multiple sclerosis. J Immunol 1976; 117:1906-1912.
43. Vandiedonck C, TaylorMS, Lockstone HE, et al. Pervasive haplotypic variation in the spliceo-transcriptome of the human major histocompatibility complex. Genome Res 2011; 21:1042-1054.
44. Mars LT, Saikali P, Liblau RS, Arbour N. Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models. Biochim Biophys Acta 2011; 1812:151-161.
45. Tsuchida T, Parker KC, Turner RV, et al. Autoreactive CD8p T-cell responses to human myelin protein-derived peptides. Proc Natl Acad Sci USA 1994; 91:10859-10863.
46. Honma K, Parker KC, Becker KG, et al. Identification of an epitope derived from human proteolipid protein that can induce autoreactive CD8p cytotoxic T lymphocytes restricted by HLA-A3: evidence for cross-reactivity with an environmental microorganism. J Neuroimmunol 1997; 73:7-14. (Pubitemid 27105264)
47. Padovan E, Giachino C, Cella M, et al. Normal T lymphocytes can express two different T cell receptor b chains: implications for the mechanism of allelic exclusion. J Exp Med 1995; 181:1587-1591.
48. Davodeau F, Peyrat M-A, RomagnéF, et al. Dual T cell receptor b chain expression on human T lymphocytes. J Exp Med 1995; 181:1391-1398.
49. Padovan E, Casorati G, Dellabona P, et al. Expression of two T cell receptor a chains: dual receptor T cells. Science 1993; 262:422-424. (Pubitemid 23353384)
50. Heath WR, Miller JFAP. Expression of two a chains on the surface of T cells in T cell receptor transgenic mice. J Exp Med 1993; 178:1807-1811. (Pubitemid 23318462)
51. Corthay A, Nandakumar KS, Holmdahl R. Evaluation of the percentage of peripheral T cells with two different T cell receptor a-chains and of their potential role in autoimmunity. J Autoimmun 2001; 16:423-429. (Pubitemid 32579004)
52. Alli R, Nguyen P, Boyd K, et al. A mouse model of clonal CD8p T lymphocytemediated alopecia areata progressing to alopecia universalis. J Immunol 2012; 188:477-486.
53. Alli R, Nguyen P, Geiger TL. Retrogenic modeling of experimental allergic encephalomyelitis associates T cell frequency but not TCR functional affinity with pathogenicity. J Immunol 2008; 181:136-145.
54. Libbey JE, Cusick MF, Tsunoda I, Fujinami RS. Antiviral CD8p T cells cause an experimental autoimmune encephalomyelitis-like disease in naive mice. J NeuroVirol 2012; 18:45-54.
55. Ji Q, Perchellet A, Goverman JM. Viral infection triggers central nervous system autoimmunity via activation of CD8p T cells expressing dual TCRs. Nat Immunol 2010; 11:628-634.
56. Tsunoda I, Lane TE, Blackett J, Fujinami RS. Distinct roles for IP-10/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10. Mult Scler 2004; 10:26-34. (Pubitemid 38100523)
57. Tsunoda I, Kuang L-Q, Fujinami RS. Induction of autoreactive CD8p cytotoxic cells during Theiler's murine encephalomyelitis virus infection: implications for autoimmunity. J Virol 2002; 76:12834-12844. (Pubitemid 35386967)
58. Tsunoda I, Libbey JE, Kobayashi-Warren M, Fujinami RS. IFN-g production and astrocyte recognition by autoreactive T cells induced by Theiler's virus infection: role of viral strains and capsid proteins. J Neuroimmunol 2006; 172:85-93. (Pubitemid 43277493)
59. Elliott JI, Altmann DM. Dual T cell receptor a chain T cells in autoimmunity. J Exp Med 1995; 182:953-959.
60. He X, Janeway CA Jr, Levine M, et al. Dual receptor T cells extend the immune repertoire for foreign antigens. Nat Immunol 2002; 3:127-134. (Pubitemid 34141442)
61. Sharma R, Ju ACY, Kung JT, et al. Rapid and selective expansion of nonclonotypic T cells in regulatory T cell-deficient, foreign antigen-specific TCR-transgenic scurfy mice: antigen-dependent expansion and TCR analysis. J Immunol 2008; 181:6934-6941.
62. Zhou P, Borojevic R, Streutker C, et al. Expression of dual TCR on DO11.10 T cells allows for ovalbumin-induced oral tolerance to prevent T cell-mediated colitis directed against unrelated enteric bacterial antigens. J Immunol 2004; 172:1515-1523. (Pubitemid 38116795)
63. Gavin MA, Rudensky AY. Dual TCR T cells: gaining entry into the periphery. Nat Immunol 2002; 3:109-110. (Pubitemid 34141436)
64. Legrand N, Freitas AA. CD8p T lymphocytes in double ab TCR transgenic mice. II. Competitive fitness of dual ab TCR CD8p T lymphocytes in the peripheral pools. J Immunol 2001; 167:6158-6164. (Pubitemid 33081542)
65. Paterson RK, Bluethmann H, Tseng P, et al. Development and function of autospecific dual TCRp T lymphocytes. Int Immunol 1999; 11:113-119. (Pubitemid 29037594)
66. Munthe LA, Sollien A, Dembic Z, Bogen B. Preferential positive selection of T lymphocytes which express two different TCR alpha chains, an endogenous and a transgenic. Scand J Immunol 1995; 42:651-661. (Pubitemid 26009084)